Related references
Note: Only part of the references are listed.Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Danyu Du et al.
ACTA PHARMACEUTICA SINICA B (2022)
The gut microbiome-bile acid axis in hepatocarcinogenesis
Liwei Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
The Evolving Landscape of Noncanonical Functions of Metabolic Enzymes in Cancer and Other Pathologies
Daqian Xu et al.
CELL METABOLISM (2021)
PPARγ/NF-κB and TGF-β1/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis
Qiang Yu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study
Young Youn Cho et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)
Emerging roles of aerobic glycolysis in breast cancer
Z. Wu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis-Driven Hepatocarcinogenesis via ERK-Dependent PKM2 Nuclear Relocalization and Activation
Tin-Lok Wong et al.
HEPATOLOGY (2020)
Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis
Jiao Feng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis
Marc Mejias et al.
GASTROENTEROLOGY (2020)
Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma
Jiao Feng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2
Chunqing Wang et al.
NATURE COMMUNICATIONS (2020)
Simultaneous Induction of Glycolysis and Oxidative Phosphorylation during Activation of Hepatic Stellate Cells Reveals Novel Mitochondrial Targets to Treat Liver Fibrosis
Natalia Smith-Cortinez et al.
CELLS (2020)
Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma
Qiang Yu et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2020)
Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis
Dandan Zheng et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma
Jeong-Ju Yoo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression
Peter Vaupel et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2019)
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy
Elisa Lozano et al.
HEPATOLOGY (2019)
PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma
Jiao Feng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers
Shili Xu et al.
CANCER RESEARCH (2019)
Costunolide reduces glycolysis-associated activation of hepatic stellate cells via inhibition of hexokinase-2
Dujing Ban et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2019)
Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer
Sehui Kim et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Anti-Cancer Effects of Emodin on HepG2 Cells as Revealed by H-1 NMR Based Metabolic Profiling
Yue-Xiao Xing et al.
JOURNAL OF PROTEOME RESEARCH (2018)
Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin
Dannielle DeWaal et al.
NATURE COMMUNICATIONS (2018)
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies
Maria Apicella et al.
CELL METABOLISM (2018)
Histone deacetylase inhibitors in hepatocellular carcinoma: A therapeutic perspective
Diamantis Tsilimigras et al.
SURGICAL ONCOLOGY-OXFORD (2018)
2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells
Minoru Tomizawa et al.
ONCOLOGY LETTERS (2017)
By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma
Sainan Li et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Butyrate restores HFD-induced adaptations in brain function and metabolism in mid-adult obese mice
I. A. C. Arnoldussen et al.
INTERNATIONAL JOURNAL OF OBESITY (2017)
Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2
Dong Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier
Da Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Methyl jasmonate leads to necrosis and apoptosis in hepatocellular carcinoma cells via inhibition of glycolysis and represses tumor growth in mice
Jingjing Li et al.
ONCOTARGET (2017)
Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death
Sainan Li et al.
BRITISH JOURNAL OF CANCER (2017)
Oxidative stress plays a key role in butyrate-mediated autophagy via Akt/mTOR pathway in hepatoma cells
Kishor Pant et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities
Shanmugasundaram Ganapathy-Kanniappan
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
HKDC1 Is a Novel Hexokinase Involved in Whole-Body Glucose Use
Anton E. Ludvik et al.
ENDOCRINOLOGY (2016)
Measuring relative utilization of aerobic glycolysis in breast cancer cells by positional isotopic discrimination
Da-Qing Yang et al.
FEBS LETTERS (2016)
Sodium butyrate protects against oxidative stress in HepG2 cells through modulating Nrf2 pathway and mitochondrial function
Xingan Xing et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2016)
The HK2 Dependent Warburg Effect and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate
Pawel Lis et al.
MOLECULES (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein
Juliana F. Ortega et al.
ONCOTARGET (2016)
Reciprocal Modulation of Histone Deacetylase Inhibitors Sodium Butyrate and Trichostatin A on the Energy Metabolism of Breast Cancer Cells
Mariana Figueiredo Rodrigues et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice
Weiqi Dai et al.
ONCOTARGET (2015)
Review of aerobic glycolysis and its key enzymes - new targets for lung cancer therapy
Xue-bing Li et al.
THORACIC CANCER (2015)
CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway
Qichao Huang et al.
JOURNAL OF HEPATOLOGY (2014)
A long noncoding RNA connects c-Myc to tumor metabolism
Chiu-Lien Hung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer
Krushna C. Patra et al.
CANCER CELL (2013)
Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro
Hong-Gang Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
Dual effects of sodium butyrate on hepatocellular carcinoma cells
Wenjun Jiang et al.
MOLECULAR BIOLOGY REPORTS (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Energy Metabolism in H460 Lung Cancer Cells: Effects of Histone Deacetylase Inhibitors
Nivea Dias Amoedo et al.
PLOS ONE (2011)
Hep G2 is a hepatoblastoma-derived cell line
Dolores Lopez-Terrada et al.
HUMAN PATHOLOGY (2009)
Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak
N Majewski et al.
MOLECULAR CELL (2004)
Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of β-catenin, pRb and Bcl-XL
S Emanuele et al.
EUROPEAN JOURNAL OF CANCER (2004)
Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function
JE Wilson
JOURNAL OF EXPERIMENTAL BIOLOGY (2003)
Share Paper
